Gibson, Dunn & Crutcher LLP advised Royalty Pharma in connection with its development funding. Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals International GmbH, a subsidiary...
Royalty Pharma’s Partnership with Teva Pharmaceuticals International GmbH
Venator’s Chapter 11 Restructuring
Simpson Thacher & Bartlett advised JPMorgan Chase Bank, N.A., as administrative agent and lender, on the restructuring, and Gibson Dunn & Crutcher advised Cross-Holder Group. Venator...
Appian Capital Advisory LLP’s Closing of $2.06 Billion Fund III
Gibson, Dunn & Crutcher LLP advised Appian Capital Advisory LLP on the matter. Appian Capital Advisory LLP, the investment advisor to long-term value focused private capital funds that...
KKR & Co. Inc.’s Acquistion of Clinisupplies
Gibson Dunn & Crutcher LLP advised New York-based investment company KKR & Co. Inc. (KKR) on its acquisition of Clinisupplies from Healthium. KKR was also advised...
RedBird Capital Partners’s €1.2 Billion Acquisition of AC Milan
Davis Polk & Wardwell advised an affiliate of Elliott Management in the deal. Gibson, Dunn & Crutcher LLP and Legance have acted for RedBird Capital Partner....
MIESCOR Infrastructure Development Corporation’s P26.2 Billion Acquisition of Telecom Towers from Globe Telecom Inc.
Gibson Dunn advised MIESCOR Infrastructure Development Corporation, while Herbert Smith Freehills has advised Globe Telecom Inc. Stonepeak, through Miescor Infrastructure Development Corporation (MIDC), have signed definitive agreements...